HIV News Media Resources
World AIDS Day 2022 Media Statement – December 1, 2022
COVID-19 disruptions in HIV testing and prevention
highlight need for innovation and investment before the next public health emergency.
HIV testing dropped sharply during first year of COVID-19 – June 23, 2022
New CDC data show a sharp decrease in the number of CDC-funded HIV tests administered from 2019 to 2020, including concerning drops among groups disproportionately affected by HIV.
CDC Data Highlights Factors that Contribute to Continuing HIV Disparities in the U.S. – February 3, 2022
Despite overall progress in reducing HIV transmission in the United States, HIV continues to affect some groups more than others due to longstanding and ingrained barriers. Black or African American (hereafter referred to as Black) people account for a higher proportion of new HIV infections, compared to other races and ethnicities. Black people accounted for 13% of the U.S. population but 40% of people with HIV in 2019, according to CDC estimates.
New CDC Vital Signs report reveals a decade of continuing HIV inequities – November 30, 2021
Despite overall progress in reducing new infections among gay and bisexual men, the HIV epidemic continued and was more severe among Black and Hispanic/Latino gay and bisexual men in the decade leading up to the federal Ending the HIV Epidemic in the U.S. initiative.
CDC Awards $117 Million to Advance Innovation and Health Equity in Federal Initiative to End HIV – July 27, 2021
CDC awarded $117 million to state and local health departments to help rebuild and begin to expand HIV prevention and treatment efforts as the U.S. continues to respond to COVID-19. The awards are part of the federal Ending the HIV Epidemic in the U.S. (EHE) initiative, which funds 57 priority areas to expand and tailor key HIV prevention strategies to community needs.
New CDC data show new HIV infections fell 8% from 2015 to 2019, after a period of general stability in new infections in the U.S. These data suggest recent progress is likely due to increased uptake of key prevention and treatment strategies. However, to reach the Ending the HIV Epidemic in the U.S goals, addressing continued disparities will be crucial.
A CDC report released in advance of National Transgender HIV Testing Day found that four in ten transgender women surveyed in seven major U.S. cities have HIV. These findings demonstrate the pressing need for scaled-up HIV prevention and care strategies for transgender women.
2021 Conference on Retroviruses and Opportunistic Infections – March 6-10, 2021
CDC scientists will present nearly 30 abstracts at the 2021 Conference on Retroviruses and Opportunistic Infections (CROI). The conference will be held virtually from March 6-10, 2021. Several studies that may be of particular interest represent two main research areas: COVID-19’s impact on HIV testing and treatment, and disparities among people with HIV.
HIV-Related Death Rate in U.S. Fell by Half – November 19, 2020
New CDC data show that the rate of HIV-related deaths among people 13 years and older in the United States fell by nearly half from 2010 to 2017. Despite this progress, action is still needed to further reduce HIV deaths, prevent new transmissions, and end disparities.
CDC Awards $109 Million to Local Areas and States for Federal Initiative to End the HIV Epidemic in the U.S. – July 31, 2020
CDC awarded $109 million to areas most affected by HIV in order to accelerate progress in the fight to end the HIV epidemic in the U.S. Communities will use the funding to customize and implement high-impact HIV diagnosis, treatment, prevention, and response strategies, and to reduce local barriers to HIV prevention and care.
CDC scientists will present more than 20 abstracts at the 23rd International AIDS Conference. The conference will be held virtually from July 6-10, 2020, and feature CDC research on important HIV/AIDS topics, including key prevention strategies, testing and engagement in care, and risk behavior/key population trends.
CDC Vital Signs: Ending HIV Transmission — Test, Treat, and Prevent – December 3, 2019
Far too many Americans with HIV are unaware that they have it. Far too few have the virus under control through effective treatment. And far too few Americans at risk for HIV are taking the daily pill that prevents HIV.
HHS Awards $13.5 Million to Accelerate State and Local Planning Efforts for Ending the HIV Epidemic: A Plan for America – October 2, 2019
The U.S. Department of Health and Human Services (HHS), through CDC, has awarded funds to conduct state and local planning and kick off community involvement for the proposed federal initiative to end the HIV epidemic in America.
Most Americans Have Never Had an HIV Test, New Data Show – June 27, 2019
New CDC data show that most people in the United States have never had an HIV test – though CDC recommends that everyone between the ages of 13 – 64 years be screened at least once in their lifetime.
Leading HIV Experts Convene 2019 National HIV Prevention Conference – March 18, 2019
In support of the conference theme – Getting to No New Infections – speakers, including U.S. Secretary of Health and Human Services Alex M. Azar II, CDC Director Robert R. Redfield, M.D., National Institute of Allergy and Infectious Diseases Director Anthony S. Fauci, M.D., Health Resources & Services Administration HIV/AIDS Bureau Associate Administrator, Laura Cheever, M.D., and NCHHSTP Director Jonathan Mermin, M.D., will share their vision and insights on the coordinated federal effort to eliminate HIV in the United States within a decade: Ending the HIV Epidemic: A Plan for America.
CDC Vital Signs: HIV Transmission along the Continuum of Care, 2016 – March 18, 2019
Published on the first day of CDC’s 2019 National HIV Prevention Conference, a new CDC Vital Signs report provides the latest data on the impact of undiagnosed and untreated HIV in the nation and underscores the critical need to expand HIV testing and treatment in the U.S.
2019 Conference on Retroviruses and Opportunistic Infections – March 7, 2019
A new CDC analysis presented today at the Conference on Retroviruses and Opportunistic Infections in Seattle, Washington finds more gay and bisexual men at high risk for HIV are using pre-exposure prophylaxis (PrEP), but significant gaps remain – especially among African Americans and Latinos.
Progress in HIV prevention has stalled; need for immediate action — ‘Ending the Epidemic: A Plan for America’ – February 27, 2019
Annual HIV infections (“HIV incidence”) in the United States have been reduced by more than two-thirds since the height of the epidemic in the mid-1980s, but CDC data indicate that progress has stalled in recent years. Following about five years of declines, the estimated number of new HIV infections began to level off in 2013 at about 39,000 per year — reinforcing the need for more action to end America’s HIV epidemic. The report also finds that new HIV infections declined in some populations, but increased in others.
2018 Conference on Retroviruses and Opportunistic Infections – March 6, 2018
A new CDC analysis presented today at the Conference on Retroviruses and Opportunistic Infections in Boston, Mass., suggests only a small percentage of Americans who could benefit from pre-exposure prophylaxis (PrEP) have been prescribed it. Furthermore, while two-thirds of people who could potentially benefit are African American or Latino, they account for the smallest percentage of PrEP prescriptions to date. Additionally, two new CDC analyses presented at CROI demonstrate the effectiveness of SSPs and HIV testing and treatment in helping to end a large outbreak of HIV among people who inject drugs (PWID).
- New HIV infections in the U.S. fell 8% from 2015 to 2019, after a period of general stability.
- African Americans and gay & bisexual men face a heavier burden of HIV and are at higher risk for infection.
Demetre Daskalakis, MD
Director, Division of HIV Prevention
View Dr. Demetre’s full bio